Skip to content
Vion Pharmaceuticals, Inc.
  • Home
  • Company
    • Business Development
    • Historical Information
    • Corporate Governance
    • Board of Directors
    • Research & Clinical Collaborations
    • Partnering
  • Products
    • Cloretazine® (VNP40101M)
    • Onrigin™ (laromustine)
    • Triapine®
  • FAQ
  • More
    • Earnings Reports
    • Clinical Trials
    • Investor Relations
    • Annual Report
    • Press Releases
    • Information Requests
    • Sitemap
  • Contact Us
    • Directions

Site Map

Home
Contact Us
Glossary
Privacy
Terms of Use
Copyright
Site Map
Clinical Trials
Summary of Clinical Trials
• Laromustine (Cloretazine®, VNP40101M)
• Triapine®
Information for Patients
About Cancer
Cancer Links
About Vion
Officers
Board of Directors
Business Development
• Collaborations
• Partnering
Working at Vion
Contact Us
• Directions
• Feedback
Investor Relations
Stock Information
SEC Filings
Financial Information
• Earnings Reports
• Annual Report
• Analysts Coverage
Event Calendar
Historical Information
Press Releases
Shareholder Services
• Shareholder FAQ
• Annual Meeting of Stockholders
Corporate Governance
FAQs
Information Requests
E-Mail Alerts
Products & Pipeline
Laromustine (Cloretazine®, VNP40101M)
Triapine®
Stock Information

SEC Filings

Financial Information

Event Calendar

Historical Information

Press Releases

Shareholder Services

Corporate Governance

FAQs

Information Requests

E-Mail Alerts

© 2023 Vion Pharmaceuticals, Inc. • Privacy  Terms of Use   Copyright